Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03273426
What this trial is testing

Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.

Who this might be right for
Breast Neoplasm
Seoul National University Hospital 40
Not applicableEnded earlyNCT01543126
What this trial is testing

IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 9
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Not applicableLooking for participantsNCT06104085
What this trial is testing

99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Not applicableUnknownNCT05339113
What this trial is testing

Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

Who this might be right for
Breast NeoplasmsPositron Emission TomographyFibroblast Activation Protein Inhibitor+1 more
The National Center of Oncology, Azerbaijan 100
Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Large-scale testing (Phase 3)Study completedNCT00645138
What this trial is testing

Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery

Who this might be right for
Breast Cancer
Weill Medical College of Cornell University 40
Testing effectiveness (Phase 2)Ended earlyNCT02806258
What this trial is testing

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Who this might be right for
Radiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast Cancer
University Hospital, Grenoble 362
Early research (Phase 1)Study completedNCT02833155
What this trial is testing

Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Taizhou EOC Pharma Co., Ltd. 19
Early research (Phase 1)UnknownNCT03282825
What this trial is testing

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Who this might be right for
Advanced Breast Cancer
Dong Wha Pharmaceutical Co. Ltd. 18
Not applicableUnknownNCT06441240
What this trial is testing

Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.

Who this might be right for
Breast CancerChemotherapy EffectTriple Negative Breast Cancer+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 933
Not applicableStudy completedNCT01818817
What this trial is testing

Ultrasound Paravertebral Block in Breast Surgery.

Who this might be right for
Breast Cancer
Campus Bio-Medico University 20
Testing effectiveness (Phase 2)Study completedNCT00193050
What this trial is testing

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752550
What this trial is testing

Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Harbin Medical University 120
Large-scale testing (Phase 3)UnknownNCT00002455
What this trial is testing

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Who this might be right for
Breast CancerColorectal CancerMelanoma (Skin)
Centro Oncologico de Excelencia
Not applicableUnknownNCT03294343
What this trial is testing

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeColorectal Neoplasms, Hereditary NonpolyposisOvariectomy+1 more
Lei Li 600
Testing effectiveness (Phase 2)Ended earlyNCT02299635
What this trial is testing

A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Who this might be right for
Triple Negative Breast Neoplasms
Pfizer 19
Next Page